Pharmaco - Press Releases

Date	Title	Company
10-Dec-2019	Mallinckrodt Announces Plans to Update Its Incentive Compensation Clawback Policy and Create Opioid Report	Mallinckrodt plc
10-Dec-2019	Spotlight on Abzena’s Developability Platform during Antibody Engineering & Therapeutics 2019	Abzena
10-Dec-2019	Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US	Inceptua
10-Dec-2019	ArisGlobal's LifeSphere MultiVigilance Goes Live With Top 5 Pharma, Delivering a Next-generation Safety System to 2,300+ End Users	ArisGlobal
10-Dec-2019	Kristian Jürgensen promoted to Chief Commercial Officer as The RSA Group expands	Sciad Newswire
10-Dec-2019	Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy	Elekta
09-Dec-2019	ADC Therapeutics Announces Oral Presentation of Interim Efficacy Data from Pivotal Phase 2 Clinical Trial of ADCT-402 (Loncastuximab Tesirine) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma at 61st ASH Annual Meeting	ADC Therapeutics SA
09-Dec-2019	Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data	Newron Pharmaceuticals S.p.A.
09-Dec-2019	Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data	Newron Pharmaceuticals S.p.A.
09-Dec-2019	MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis	B3C newswire
09-Dec-2019	MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis	B3C newswire
09-Dec-2019	The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels	The Alliance for Regenerative Medicine
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ReNeuron Group plc - Interim Results	ReNeuron Group plc
09-Dec-2019	Professor Amit Nathwani will present the Ham-Wasserman Lecture at the 61st ASH Annual Meeting	Freeline
09-Dec-2019	BC Platforms Partners with leading European Genomics Service Provider Life & Brain to Expand Genotyping Services Across Europe	BC Platforms
09-Dec-2019	UKCPA publish recommendations to avoid errors with Syntocinon® & Syntometrine®	UKCPA
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	Takeda and Enzyre to develop diagnostic device allowing hemophilia patients to determine their coagulation status at home	Takeda Pharmaceutical Company Limited
09-Dec-2019	PureTech Affiliate Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections	PureTech Health plc